In addition to wound care products, Organogenesis is advancing an injected treatment called RENEW for painful knee osteoarthritis. On the risk side, the company has said it could see market ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Organogenesis Holdings Inc. (NASDAQ:ORGO – Get Free Report) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 11,000,000 ...

Barclays PLC boosted its holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO – Free Report) by 251.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange ...

PROVIDENCE — Rhode Island Commerce Corporation has granted Organogenesis, a Massachusetts biotech firm, more than $13 million in tax incentives, to support the company’s opening of a new ...